64 related articles for article (PubMed ID: 29662235)
1. Using machine learning to develop preoperative model for lymph node metastasis in patients with bladder urothelial carcinoma.
Ji J; Zhang T; Zhu L; Yao Y; Mei J; Sun L; Zhang G
BMC Cancer; 2024 Jun; 24(1):725. PubMed ID: 38872141
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of urine cyclic RNA-0071196 for bladder urothelial carcinoma.
Yang Y; Li J; Yao W; Zou G; Ye X; Mo Q
BMC Urol; 2024 Apr; 24(1):88. PubMed ID: 38627689
[TBL] [Abstract][Full Text] [Related]
3. The value of ATAD3A as a potential biomarker for bladder cancer.
Liu Z; Sun L; Zheng B; Wang H; Qin X; Zhang P; Wo Q; Li H; Mou Y; Zhang D; Wang S
Cancer Med; 2023 Dec; 12(24):22395-22406. PubMed ID: 38018291
[TBL] [Abstract][Full Text] [Related]
4. Rare Manifestation of the Cutaneous and Cervical Lymph Node Metastases of Urothelial Carcinoma of Urinary Bladder: A Case Report.
Sim WY; Park NH; Jung YY
J Korean Soc Radiol; 2023 Nov; 84(6):1403-1407. PubMed ID: 38107689
[TBL] [Abstract][Full Text] [Related]
5. RNA-binding proteins RBM-HuR, RBM3 and PODXL expression in urothelial carcinoma of the urinary bladder. Prognostic and clinical implications.
Hafez AM; Seleem MM; Alattar AZ; Elshorbagy S; Elsayed WSH
Contemp Oncol (Pozn); 2021; 25(4):279-290. PubMed ID: 35079236
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic significance of Ephrin A3 in bladder urothelial carcinoma.
Wang YF; Hu YN; Shen ZF; Zhao CF; Liu K; Wang H; Zhang Q
Oncol Lett; 2023 Dec; 26(6):524. PubMed ID: 37927410
[TBL] [Abstract][Full Text] [Related]
7. Preoperative Prediction of Node Metastases in Bladder Cancer Patients Using Genomic and Clinicopathologic Data.
Moschini M; Montorsi F
EBioMedicine; 2018 May; 31():5-6. PubMed ID: 29685788
[No Abstract] [Full Text] [Related]
8. Editorial Comment to A case of mixed tumor formed by metastasis of urothelial carcinoma and malignant lymphoma to the same lymph nodes.
Sekito T; Sadahira T
IJU Case Rep; 2021 Sep; 4(5):297-298. PubMed ID: 34497988
[No Abstract] [Full Text] [Related]
9. Gains of 20q11.21 in human pluripotent stem cells: Insights from cancer research.
Krivec N; Ghosh MS; Spits C
Stem Cell Reports; 2024 Jan; 19(1):11-27. PubMed ID: 38157850
[TBL] [Abstract][Full Text] [Related]
10. PLAGL2 promotes bladder cancer progression via RACGAP1/RhoA GTPase/YAP1 signaling.
Chen H; Yang W; Li Y; Ji Z
Cell Death Dis; 2023 Jul; 14(7):433. PubMed ID: 37454211
[TBL] [Abstract][Full Text] [Related]
11. Pathologic collision of urinary bladder urothelial carcinoma with small cell carcinoma: a case report.
Jiang W; Pan C; Guo W; Xu Z; Ni Q; Ruan Y
Diagn Pathol; 2023 Jul; 18(1):80. PubMed ID: 37434193
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of GATA5 Inhibits Prostate Cancer Progression by Regulating PLAGL2 via the FAK/PI3K/AKT Pathway.
Wang Q; Liu Z; Zhai G; Yu X; Ke S; Shao H; Guo J
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565203
[TBL] [Abstract][Full Text] [Related]
13. Increased NUSAP1 expression is associated with lymph node metastasis and survival prognosis in bladder urothelial carcinoma.
Hou J; Lu Z; Liu X; Luo B; Qu G; Xu Y; Tang C
Sci Rep; 2022 Apr; 12(1):7003. PubMed ID: 35487972
[TBL] [Abstract][Full Text] [Related]
14. High Expression of PLAGL2 is Associated With Poor Prognosis in High-Grade Glioma.
Wang G; Du W; Che L; Gao X; Zhao R; Duan J; Gu Z; Ma Q
Front Genet; 2021; 12():787746. PubMed ID: 35222518
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-214-3p targets the PLAGL2-MYH9 axis to suppress tumor proliferation and metastasis in human colorectal cancer.
Zhou Z; Wu L; Liu Z; Zhang X; Han S; Zhao N; Bao H; Yuan W; Chen J; Ji J; Shu X
Aging (Albany NY); 2020 May; 12(10):9633-9657. PubMed ID: 32413870
[TBL] [Abstract][Full Text] [Related]
16.
Panagopoulos I; Gorunova L; Andersen K; Lund-Iversen M; Lobmaier I; Micci F; Heim S
Cancer Genomics Proteomics; 2020; 17(3):237-248. PubMed ID: 32345665
[TBL] [Abstract][Full Text] [Related]
17. Circ-SOX4 drives the tumorigenesis and development of lung adenocarcinoma via sponging miR-1270 and modulating PLAGL2 to activate WNT signaling pathway.
Gao N; Ye B
Cancer Cell Int; 2020; 20():2. PubMed ID: 31911754
[TBL] [Abstract][Full Text] [Related]
18. Expression of PLAGL2 in bladder urothelial carcinoma and its relationship to lymph node metastasis and survival.
Qu G; Xu Y; Wan SP; Yang G
Sci Rep; 2018 Apr; 8(1):6044. PubMed ID: 29662235
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
